Quote | Applied Molecular Transport Inc. (NASDAQ:AMTI)
Last: | $0.263 |
---|---|
Change Percent: | -19.01% |
Open: | $0.313 |
Close: | $0.263 |
High: | $0.313 |
Low: | $0.2603 |
Volume: | 240,468 |
Last Trade Date Time: | 12/26/2023 03:00:00 am |
News | Applied Molecular Transport Inc. (NASDAQ:AMTI)
Combined company operating as Cyclo Therapeutics with primary focus on advancing Trappsol ® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1) Cash runway extended into 2H 2024 with approximately $11.0 million cash on hand to fund operations Cyclo ...
2023-11-09 17:41:32 ET More on Applied Molecular Transport Applied Molecular to merge with Cyclo Therapeutics in all-stock deal Seeking Alpha’s Quant Rating on Applied Molecular Transport Historical earnings data for Applied Molecular Transport Financi...
Message Board Posts | Applied Molecular Transport Inc. (NASDAQ:AMTI)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $AMTI 34% v2,4MC.6822 f38,943M H.84 ML.48 BO.6 got S@.56 then hod and back | znewcar1 | investorshangout | 02/23/2023 9:31:32 PM |
Im not sure how this stays below 2 | tcummingsvt | investorshub | 07/06/2022 12:59:42 PM |
Applied Molecular Transport to Report Top-line Phase 2 | crudeoil24 | investorshub | 07/05/2022 8:57:07 PM |
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical | crudeoil24 | investorshub | 07/05/2022 8:56:06 PM |
News, Short Squeeze, Breakout and More Instantly...
Applied Molecular Transport Inc. Company Name:
AMTI Stock Symbol:
NASDAQ Market:
Applied Molecular Transport Inc. Website:
Combined company operating as Cyclo Therapeutics with primary focus on advancing Trappsol ® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1) Cash runway extended into 2H 2024 with approximately $11.0 million cash on hand to fund operations Cyclo ...
Company Entered into Definitive Merger Agreement with Cyclo Therapeutics Cash and Cash Equivalents of $18.1 million, as of September 30, 2023 SOUTH SAN FRANCISCO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a biopharmaceut...
CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...